Aronoff presents at 2014 Kidney Week
December 11, 2014 at 4:40 PM
Never one to rest on his laurels, Assistant Chief Medical Director Dr. George Aronoff recently participated in four sessions at Kidney Week 2014, the American Society of Nephrology's meeting that brings together kidney professionals around the globe to discuss and debate the latest in kidney health. Held in Philadelphia the second week of November, 13,000 participants came to hear the latest information in the medical field. Participants network with fellow specialists, learn best practices, collaborate with colleagues and, in Dr. Aronoff's case, be a part of two panels, two presentations, and a workshop where he co-authored a white paper.
Aronoff's flight of panels and presentations started on Tuesday with an open workshop presented by the Kidney Health Initiative (KHI). The workshop's purpose was to identify workable approaches to address the paucity of data to inform the dosing of certain drugs given in the context of critical illness. A KHI workgroup has proposed possible pragmatic solutions to conducting studies in the setting of continuous renal replacement therapy that would generate informative pharmacokinetic data.
The forum was attended by representatives from the FDA, the pharmaceutical industry, pharmacologists, nephrologists, and other affected stakeholders. Dr. Aronoff was a co-author for the white paper presented for discussion called "Pharmacokinetic Assessment in Patients Receiving Continuous RRT" and one of six panelists at the discussion.
As a part of Wednesday's pre-conference courses, Dr. Aronoff presented a course on "Nephro-Pharmacology across the Spectrum of Kidney Diseases." The presentation was designed as a comprehensive review of fundamental issues related to clinical pharmacology in kidney disease, using lectures, interactive case-based discussions, and self-assessment questions with an audience response system.
At the conclusion of the program, nephrologists, pharmacists, nurses, trainees, and researchers gained up-to-date information on pharmacology and the kidneys, drug dosing, pharmacokinetics and pharmacology in acute kidney disease and CKD, and special topics in renal pharmacology.
With the conference officially underway on Thursday, November 13, Dr. Aronoff presented an educational symposium on "Oral Iron Supplementation in CKD and Dialysis Patients: An Update." The presentation tackled questions such as " Has the risk/benefit ratio of using oral iron supplementation changed?" and "Can oral iron replace intravenous (IV) iron in dialysis patients?"
Dr. Aronoff's final responsibility at Kidney Week was to participate as one of two panelists in a session on Saturday titled "Doctor, Your Patient Is Getting Worse! Are You Sure the Drug Dose Is Right?" The session provided an overview of the fundamental pharmacokinetic and dynamic principles necessary when making pharmacotherapeutic decisions in patients across the spectrum of kidney function with a focus on patients receiving intermittent and continuous dialytic techniques.
The 2015 Kidney Week will take place November 3-8 in San Diego, CA.